Literature DB >> 4004971

The immunoreactivity, ligand, and cell binding characteristics of rheumatoid synovial fluid fibronectin.

S Carsons, B B Lavietes, H S Diamond, S G Kinney.   

Abstract

Fibronectin promotes macrophage adherence and expression of Fc receptors, is chemotactic for fibroblasts, and is an opsonin for fibrin and denatured collagen. These properties suggest a role for fibronectin in the modulation of joint inflammation. Since structural modification of the fibronectin molecule has been shown to result in loss or de novo acquisition of opsonic and chemotactic activity, we determined the functional and immunochemical properties of fibronectin isolated from the inflamed joint. Eighty-six percent of synovial fluids obtained from patients with active rheumatoid arthritis (RA) contained fibronectin fragments, and 39% of the fluids no longer displayed the dimeric form. Compared with native fibronectin, RA peptides were as active in promoting synoviocyte chemotaxis and in glycosaminoglycan binding, but displayed lower affinity for fibrin and gelatin. Although comparable with intact protein in augmenting monocyte attachment to gelatin, the RA synovial fluid peptides did not augment monocyte attachment to fibrin. Analysis of whole synovial fluid and isolated fibronectins by enzyme immunoassay showed that the increased fibronectin immunoreactivity, previously reported in RA synovial fluid, measures intact and nearly intact protein and does not measure extensively degraded fragments.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4004971     DOI: 10.1002/art.1780280602

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

1.  Synovial fluid fibronectin fragments: no evidence for a mitogenic effect on fibroblasts.

Authors:  K E Herbert; P I Mapp; A M Griffiths; P A Revell; D L Scott
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

2.  Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion.

Authors:  M L Kireeva; F E MO; G P Yang; L F Lau
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  Interaction between synoviocytes and extracellular matrix in vitro.

Authors:  S E Carsons; J Wolf
Journal:  Ann Rheum Dis       Date:  1995-05       Impact factor: 19.103

4.  Fragmentation of fibronectin by inherent autolytic and matrix metalloproteinase activities.

Authors:  Bjorn Steffensen; Zhihua Chen; Sanjay Pal; Margarita Mikhailova; Jianrong Su; Yao Wang; Xiaoping Xu
Journal:  Matrix Biol       Date:  2010-10-13       Impact factor: 11.583

5.  Expression of epithelial adhesion proteins and integrins in chronic inflammation.

Authors:  K Haapasalmi; M Mäkelä; O Oksala; J Heino; K M Yamada; V J Uitto; H Larjava
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

6.  Carbohydrate heterogeneity of fibronectins. Synovial fluid fibronectin resembles the form secreted by cultured synoviocytes but differs from the plasma form.

Authors:  S Carsons; B B Lavietes; A Slomiany; H S Diamond; E Berkowitz
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

7.  Fibronectin and immune complexes in rheumatic diseases.

Authors:  K E Herbert; J S Coppock; A M Griffiths; A Williams; M W Robinson; D L Scott
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

Review 8.  The synovial fluid fibroblast-like synoviocyte: A long-neglected piece in the puzzle of rheumatoid arthritis pathogenesis.

Authors:  Dorra Elhaj Mahmoud; Wajih Kaabachi; Nadia Sassi; Lamjed Tarhouni; Sonia Rekik; Samia Jemmali; Hela Sehli; Maryam Kallel-Sellami; Elhem Cheour; Lilia Laadhar
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

9.  Electrophoretic characterization of species of fibronectin bearing sequences from the N-terminal heparin-binding domain in synovial fluid samples from patients with osteoarthritis and rheumatoid arthritis.

Authors:  John H Peters; Steven Carsons; Mika Yoshida; Fred Ko; Skye McDougall; Grace A Loredo; Theodore J Hahn
Journal:  Arthritis Res Ther       Date:  2003-09-08       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.